2-tert-butylhydroquinone has been researched along with Astrocytoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berrué, F; Boland, P; Harper, MK; Hart, S; Johnston, J; Kerr, R; McCulloch, MW | 1 |
| Davies, GF; Eftekharpour, E; Juurlink, BH; Roesler, WJ; Wu, L | 1 |
2 other study(ies) available for 2-tert-butylhydroquinone and Astrocytoma
| Article | Year |
|---|---|
Isolation of steroidal glycosides from the Caribbean sponge Pandaros acanthifolium.
Topics: Animals; Antioxidants; Astrocytoma; Caribbean Region; Glycosides; Humans; Male; Marine Biology; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Porifera; Steroids | 2012 |
Troglitazone selectively inhibits glyoxalase I gene expression.
Topics: Animals; Antioxidants; Astrocytoma; Cell Culture Techniques; Cells, Cultured; Chromans; Gene Expression Regulation, Enzymologic; Glutathione; Hepatocytes; Humans; Hydroquinones; Hypoglycemic Agents; Kinetics; Lactoylglutathione Lyase; Liver; Oxidative Stress; Rats; Rats, Sprague-Dawley; Thiazoles; Thiazolidinediones; Thiolester Hydrolases; Time Factors; Troglitazone; Tumor Cells, Cultured | 2001 |